U.S. Department of Health and Human Services (HHS) office, BARDA, awards Micron $2 million to continue its work on broadly-protecting avian and seasonal flu vaccinesSAN FRANCISCO, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, today announced the company won the Biomedical Advanced Research and Development Authority (BARDA) Patch Forward competition and presented ...